Uncontrolled Gout in Kidney Transplant Patients
Dr. Abdul Abdellatif, MD, assistant professor, Baylor College of Medicine and primary investigator on the “Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Early Data Report of a Multicenter, Open-Label, Efficacy and Safety” Study, otherwise known as PROTECT, discusses the latest data from this study that was presented at the American Society of Nephrology (ASN) 2020 (Abstract PO2481). He also explains strategies to effectively manage uncontrolled gout within the vulnerable post-transplant population that will not compromise kidney function or transplantation.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Hypertension. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Hypertension and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Hypertension?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Abdul Abdellatif, MD, assistant professor, Baylor College of Medicine and primary investigator on the “Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Early D…
- Key Point: He also explains strategies to effectively manage uncontrolled gout within the vulnerable post-transplant population that will not compromise kidney function or transplantation.
- Key Point: Abdul Abdellatif is board certified in internal medicine and nephrology.
- Key Point: He is a Fellow of the American Society of Nephrology practicing out of Houston, TX.
- Key Point: Abdellatif received his medical degree from Universidad Autonoma de Guadalajara in Mexico.
Dr. Abdul Abdellatif is board certified in internal medicine and nephrology. He is a Fellow of the American Society of Nephrology practicing out of Houston, TX. Dr. Abdellatif received his medical degree from Universidad Autonoma de Guadalajara in Mexico. He went on to complete his residency and fellowship at the University of Texas Health Science Center at San Antonio. Dr. Abdellatif is the founder of Kidney Hypertension Transplant Clinic at Clear Lake Specialties in Webster, Texas. He is an Adjunct Assistant Professor of Medicine – Division of Nephrology at Baylor College of Medicine.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



